In the published article, there was an error. There was a data error in the abstract.
A correction has been made to the Abstract, Results, Paragraph 1. This sentence previously stated:
“The median overall survival of H3K27M-mutant gliomas and the 80 H3K27M wild-type gliomas were both 12 months”.
The corrected sentence appears below:
“The median overall survival of H3K27M-mutant gliomas and the 70 H3K27M wild-type gliomas were both 17 months”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
midline glioma, H3K27M, clinicopathological study, prognosis, age
Citation
Hu XM, Nie X, Xu K, Wang Y, Tang F, Du Z and Xiong J (2023) Corrigendum: H3K27M mutation doesn’t mean worse prognosis in old patients. Front. Oncol. 12:1061604. doi: 10.3389/fonc.2022.1061604
Received
04 October 2022
Accepted
30 December 2022
Published
12 January 2023
Volume
12 - 2022
Edited and reviewed by
Pankaj Pathak, National Institutes of Health (NIH), United States
Updates
Copyright
© 2023 Hu, Nie, Xu, Wang, Tang, Du and Xiong.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zun guo Du, duzunguo@sina.com.cn; Ji Xiong, dabenx@163.com
†These authors share first authorship
This article was submitted to Neuro-Oncology and Neurosurgical Oncology, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.